SCHEMBL19919461

SCHEMBL19919461

N#Cc1cc(-n2c3cc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)ccc3c3ccc(-c4cc(C(F)(F)F)cc(C(F)(F)F)c4)cc32)c(-c2ccncc2)cc1-n1c2cc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)ccc2c2ccc(-c3cc(C(F)(F)F)cc(C(F)(F)F)c3)cc21

nearest known ligand 0.37

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CYP11B1 P15538 1/20 0.37
CYP11B2 P19099 1/20 0.37
S1PR1 P21453 2/20 0.36
S1PR3 Q99500 2/20 0.36
METAP2 P50579 2/20 0.36
KIF11 P52732 2/20 0.35
EPHX2 P34913 2/20 0.34
SQOR Q9Y6N5 1/20 0.33
SCN5A Q14524 1/20 0.33
SCN9A Q15858 1/20 0.33
XDH P47989 1/20 0.32
GPBAR1 Q8TDU6 1/20 0.32
CTSS P25774 1/20 0.32
CTSK P43235 1/20 0.32
RXRA P19793 1/20 0.31
RXRG P48443 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19919460 0.96 CYP11B1 (0.35) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL22019654 0.94 CYP11B1 (0.34) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL19913115 0.93 CYP11B1 (0.34) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL19919773 0.93 METAP2 (0.40) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL19919686 0.92 CYP11B1 (0.37) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL19917927 0.91 CYP11B1 (0.36) CYP11B1CYP11B2KIF11CTSSCTSK
SCHEMBL19919772 0.90 METAP2 (0.37) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL20923768 0.90 METAP2 (0.37) CYP11B1CYP11B2METAP2EPHX2SCN5A
SCHEMBL19919458 0.90 CYP11B1 (0.35) CYP11B1CYP11B2S1PR1S1PR3METAP2
SCHEMBL20923830 0.90 METAP2 (0.37) CYP11B1CYP11B2S1PR1S1PR3METAP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11588114-B2 Organic molecules for use in optoelectronic devices SAMSUNG DISPLAY CO., LTD. (KR) 2023-02-21 US disclosed
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES CYNORA GMBH (DE) 2020-07-02 US disclosed
US-20180062085-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES SAMSUNG DISPLAY CO., LTD. (KR) 2018-03-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200212316-A1 ORGANIC MOLECULES FOR USE IN OPTOELECTRONIC DEVICES OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885S1PR1 2957/4885
US-11588114-B2 Organic molecules for use in optoelectronic devices OR10J3, OPRM1, OR51E2 CYP11B1 610/4885CYP11B2 402/4885S1PR1 2957/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.